News | May 28, 2025
Fluor-built Bayer cell therapy facility in California achieves LEED v4 platinum certification
Facility also named 2025 ISPE Facility of the Year Winner for Social Impact - Unmet Medical Needs
Facility also named 2025 ISPE Facility of the Year Winner for Social Impact - Unmet Medical Needs
This global affiliation marks a critical step in the company’s mission to create long-term value through ethical practices, scientific innovation, and inclusive healthcare delivery
Glatiramer Acetate is the generic version of Copaxone 20 mg/ml, 40 mg/ml, Single-Dose Prefilled Syringes
The portfolio consists of liquids and immediate release solid orals which are in the therapeutic segment to treat infections associated with UTIs
Planned acquisition will strengthen the presence of Merck Healthcare in the United States and expand reach of SpringWorks’ therapeutic innovations to more patients with rare tumors worldwide
Bayer expects 2025 to be the most difficult year of its turnaround
Phytonadione Injectable Emulsion possesses the same type and degree of activity as does naturally-occurring vitamin K
The capital raise will also support debt repayment or prepayment, improving the company's debt-to-equity ratio and overall financial resilience
Vote expands existing recommendation, which was for all adults aged 75 and older and high-risk adults aged 60 to 74
The discontinuation decision is only on the basis of commercial reasons and is not due to efficacy or safety reasons
Subscribe To Our Newsletter & Stay Updated
